Immunic (NASDAQ:IMUX) Upgraded at Brookline Cap M
Brookline Cap M upgraded shares of Immunic (NASDAQ:IMUX – Free Report) to a strong-buy rating in a research note released on Tuesday,Zacks.com reports. Brookline Cap M also issued estimates for Immunic’s Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($0.65) EPS, Q1 2026 earnings at ($0.13) EPS, Q2 2026 earnings at ($0.12) EPS, Q3 […]
6 Feb 23:30 · The Markets Daily